22 days ago
ORKA
AnalystsYatin SunejaYatin Suneja's Stock Forecasts
AnalystsYatin Suneja
Analyst Ranking
Top 2%
#101 out of 5263 analysts
Average Return
+32.24%
Win Rate
61%100 out of 165
Risk vs Reward
Poor
Good
Yatin Suneja's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alumis IncALMS | +641.96% | $3.36 | $24.93 | 2025-06-09 - 2026-04-24 | Strong Buy |
Immunic IncIMUX | +604.08% | $1.25 | $8.80 | 2026-03-23 - 2026-04-24 | Strong Buy |
Reata Pharmaceuticals IncRETA | +376.00% | $36.21 | $172.36 | 2022-10-18 - 2023-09-25 | Strong Buy |
Phathom Pharmaceuticals IncPHAT | +323.91% | $2.76 | $11.70 | 2025-05-01 - 2026-04-24 | Strong Buy |
Zura Bio LtdZURA | +320.97% | $1.34 | $5.62 | 2025-03-25 - 2026-03-25 | Strong Buy |
Yatin Suneja Analyst Color
Get additional color on Yatin Suneja's coverage of popular stocks
a month ago
AXSM
a month ago
CABA
a month ago
ZBIO
2 months ago
DNTH
2 months ago
PHAT
3 months ago
PRAX
4 months ago
ALMS
4 months ago
DBVT
5 months ago
PRAX
6 months ago
IFRX
6 months ago
PRAX
7 months ago
ABVX
7 months ago
ACET
7 months ago
ROIV
9 months ago
NBIX
9 months ago
ARGX
9 months ago
ABVX
a year ago
ARGX
2 years ago
SYRE
2 years ago
CLDX
2 years ago
AXSM
2 years ago
LBPH
3 years ago
ARGX
3 years ago
ARGX
Yatin Suneja's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Inflarx NvIFRX | 6 | Strong Buy | $14.00 | +845.95% | Reiterates | 6 days ago |
Oruka Therapeutics IncORKA | 5 | Strong Buy | $125.00 | +81.08% | Reiterates | 14 days ago |
Neumora Therapeutics IncNMRA | 3 | Strong Buy | $14.00 | +522.22% | Reiterates | a month ago |
Dbv Technologies SaDBVT | 3 | Strong Buy | $51.00 | +157.58% | Reiterates | a month ago |
Axsome Therapeutics IncAXSM | 10 | Strong Buy | $245.00 | +31.75% | Maintains | a month ago |
Cabaletta Bio IncCABA | 7 | Strong Buy | $16.00 | +442.37% | Maintains | a month ago |
Immunic IncIMUX | 1 | Strong Buy | $70.00 | +695.36% | Initiates Coverage On | a month ago |
Zenas Biopharma IncZBIO | 3 | Strong Buy | $55.00 | +202.36% | Maintains | a month ago |
Adicet Bio IncACET | 4 | Strong Buy | $100.00 | +1,165.82% | Maintains | 2 months ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $200.00 | +128.86% | Maintains | 2 months ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $50.00 | +31.20% | Maintains | 2 months ago |
Phathom Pharmaceuticals IncPHAT | 4 | Strong Buy | $25.00 | +113.68% | Maintains | 2 months ago |
Argenx SeARGX | 12 | Strong Buy | $1,120.00 | +43.54% | Maintains | 2 months ago |
Praxis Precision Medicines IncPRAX | 5 | Strong Buy | $800.00 | +132.01% | Maintains | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 9 | Strong Buy | $975.00 | +29.73% | Maintains | 3 months ago |
Biogen IncBIIB | 4 | Strong Buy | $246.00 | +33.42% | Maintains | 3 months ago |
Roivant Sciences LtdROIV | 4 | Strong Buy | $30.00 | +9.45% | Maintains | 3 months ago |
Immunovant IncIMVT | 5 | Strong Buy | $44.00 | +53.95% | Maintains | 3 months ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $50.00 | +259.20% | Initiates Coverage On | 3 months ago |
Alumis IncALMS | 3 | Strong Buy | $32.00 | +28.36% | Maintains | 4 months ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $15.00 | +326.14% | Initiates Coverage On | 4 months ago |
Anaptysbio IncANAB | 10 | Strong Buy | $100.00 | +69.84% | Maintains | 6 months ago |
Rapt Therapeutics IncRAPT | 3 | Strong Buy | $70.00 | +20.65% | Initiates Coverage On | 6 months ago |
Abivax SaABVX | 3 | Strong Buy | $150.00 | +30.94% | Maintains | 7 months ago |
Moonlake ImmunotherapeuticsMLTX | 4 | Strong Buy | $20.00 | +16.41% | Maintains | 7 months ago |
Tourmaline Bio IncTRML | 3 | Hold | $48.00 | +0.04% | Downgrades | 8 months ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $75.00 | +173.22% | Initiates Coverage On | 8 months ago |
Neurocrine Biosciences IncNBIX | 6 | Strong Buy | $175.00 | +37.06% | Maintains | 9 months ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $26.00 | +472.69% | Reiterates | 10 months ago |
Gh Research PLCGHRS | 1 | Strong Buy | $29.00 | +43.21% | Maintains | a year ago |
Zura Bio LtdZURA | 2 | Strong Buy | $15.00 | N/A | Reiterates | a year ago |
Surrozen IncSRZN | 3 | Strong Buy | $45.00 | N/A | Upgrades | a year ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $65.00 | N/A | Maintains | 2 years ago |
Vigil Neuroscience IncVIGL | 2 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Q32 Bio IncQTTB | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 2 years ago |
Celldex Therapeutics IncCLDX | 4 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $32.00 | N/A | Maintains | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $49.00 | N/A | Reiterates | 3 years ago |
Eyepoint IncEYPT | 2 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Bioxcel Therapeutics IncBTAI | 2 | Strong Buy | $736.00 | N/A | Maintains | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Hold | $200.00 | N/A | Downgrades | 3 years ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $22.00 | N/A | Upgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $116.50 | N/A | Downgrades | 3 years ago |
Sage Therapeutics IncSAGE | 3 | Strong Buy | $48.00 | N/A | Maintains | 3 years ago |
Reata Pharmaceuticals IncRETA | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 4 years ago |
Relmada Therapeutics IncRLMD | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $330.00 | N/A | Maintains | 4 years ago |
Bausch & Lomb CorpBLCO | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Climb Bio IncCLYM | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Seelos Therapeutics IncSEELQ | 1 | Strong Buy | $30,720.00 | N/A | Initiates Coverage On | 5 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Seagen IncSGEN | 1 | Strong Buy | $80.00 | N/A | Upgrades | 8 years ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.